Price to Book Value Chart

View Price to Book Value for TCRT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2006. Start Trial.
Date Value
September 09, 2026 5.948
September 08, 2026 5.986
September 04, 2026 6.215
September 03, 2026 6.292
September 02, 2026 6.368
September 01, 2026 6.330
August 31, 2026 6.482
August 28, 2026 6.120
August 27, 2026 6.330
August 26, 2026 6.772
August 25, 2026 6.825
August 24, 2026 6.558
August 21, 2026 6.711
August 20, 2026 6.864
August 19, 2026 7.168
August 18, 2026 7.168
August 17, 2026 7.283
August 14, 2026 7.359
August 13, 2026 7.588
August 12, 2026 7.626
August 11, 2026 7.512
August 10, 2026 7.550
August 07, 2026 7.588
August 06, 2026 7.588
August 05, 2026 7.702
Date Value
August 04, 2026 7.245
August 03, 2026 7.264
July 31, 2026 7.168
July 30, 2026 7.168
July 29, 2026 7.245
July 28, 2026 7.245
July 27, 2026 7.359
July 24, 2026 7.397
July 23, 2026 7.321
July 22, 2026 7.435
July 21, 2026 7.969
July 20, 2026 7.740
July 17, 2026 7.817
July 16, 2026 7.893
July 15, 2026 8.122
July 14, 2026 7.969
July 13, 2026 7.946
July 10, 2026 7.817
July 09, 2026 7.893
July 08, 2026 7.893
July 07, 2026 7.779
July 06, 2026 8.198
July 02, 2026 7.931
July 01, 2026 8.236
June 30, 2026 8.618

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 17.69
Anika Therapeutics, Inc. 2.045
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.615

Price to Book Value Related Metrics

PS Ratio 1114.08
Price 1.50
Earnings Yield -129.9%
Market Cap 3.729M